Project Renewal: US FDA's Plan To Update Generic Cancer Drug Labels Depends On NDA Holders

Agency has targeted 40 older generic chemotherapeutics for revised labeling; FDA will develop the new labeling, which will include currently accepted uses, but needs the cooperation of reference product holders who would actually have to submit the supplement.